Plexxikon Inc. v. Novartis Pharmaceuticals Corporation

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA

PLEXXIKON INC., Case No. 4:17-cv-04405-HSG

8 Plaintiff, ORDER REGARDING MOTIONS TO vs. EXCLUDE DAMAGES EXPERTS’

OPINIONS

NOVARTIS PHARMACEUTICALS Re: Dkt. Nos. 169, 202

CORPORATION,

11 Defendant.

Pending before the Court are the parties’ motions to exclude certain expert opinions and testimony related to damages. Plaintiff Plexxikon Inc. (“Plexxikon”) moves to exclude opinions and testimony of defendant’s damages expert, James E. Malackowski. Dkt. No. 169 (“Pl. Mot.”). Defendant Novartis Pharmaceuticals Corporation’s (“Novartis”) moves to exclude the testimony of plaintiff’s damages expert, Gregory J. Leonard. Dkt. No. 202 (“Def. Mot.”). The Court heard oral argument on these motions on November 1, 2019. See Dkt. No. 341. As detailed below, the Court DENIES Novartis’ motion and GRANTS IN PART and DENIES IN PART Plexxikon’s motion. I. BACKGROUND This is a patent infringement case related to Plexxikon’s patents for kinase…